Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas DeLoughery

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|September 13, 2013
ACP Journal Club. Warfarin continuation was better than heparin bridging during pacemaker or ICD surgeryThomas Deloughery
Annals of Internal Medicine|December 18, 2013
ACP Journal Club. Review: Contemporary oral contraceptives are associated with venous thromboembolism and strokeThomas DeLoughery
Annals of Internal Medicine|September 17, 2019
Guideline: EULAR provided recommendations for thrombotic and obstetric antiphospholipid syndromeThomas DeLoughery
Annals of Internal Medicine|November 20, 2018
Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapyThomas DeLoughery
Annals of Internal Medicine|April 19, 2016
18F-fluorodeoxyglucose PET/CT added to screening after unprovoked VTE did not increase cancer detectionThomas DeLoughery
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolismThomas Deloughery
Annals of Internal Medicine|October 16, 2013
ACP Journal Club. Apixaban was noninferior to enoxaparin plus warfarin in patients with acute venous thromboembolismThomas Deloughery
Annals of Internal Medicine|February 28, 2017
Guideline: A hemoglobin threshold of 7 to 8 g/dL is recommended for hemodynamically stable hospitalized patientsThomas DeLoughery
Annals of Internal Medicine|April 21, 2015
ACP Journal Club: review: apixaban reduces bleeding and mortality compared with vitamin K antagonistsThomas DeLoughery
Annals of Internal Medicine|November 18, 2014
ACP Journal Club: review: in AF with CKD, novel oral anticoagulants reduce stroke or systemic embolism compared with warfarinThomas DeLoughery
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|September 13, 2013
ACP Journal Club. Warfarin continuation was better than heparin bridging during pacemaker or ICD surgeryThomas Deloughery
Annals of Internal Medicine|December 18, 2013
ACP Journal Club. Review: Contemporary oral contraceptives are associated with venous thromboembolism and strokeThomas DeLoughery
Annals of Internal Medicine|September 17, 2019
Guideline: EULAR provided recommendations for thrombotic and obstetric antiphospholipid syndromeThomas DeLoughery
Annals of Internal Medicine|November 20, 2018
Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapyThomas DeLoughery
Annals of Internal Medicine|April 19, 2016
18F-fluorodeoxyglucose PET/CT added to screening after unprovoked VTE did not increase cancer detectionThomas DeLoughery
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolismThomas Deloughery
Annals of Internal Medicine|October 16, 2013
ACP Journal Club. Apixaban was noninferior to enoxaparin plus warfarin in patients with acute venous thromboembolismThomas Deloughery
Annals of Internal Medicine|February 28, 2017
Guideline: A hemoglobin threshold of 7 to 8 g/dL is recommended for hemodynamically stable hospitalized patientsThomas DeLoughery
Annals of Internal Medicine|April 21, 2015
ACP Journal Club: review: apixaban reduces bleeding and mortality compared with vitamin K antagonistsThomas DeLoughery
Annals of Internal Medicine|November 18, 2014
ACP Journal Club: review: in AF with CKD, novel oral anticoagulants reduce stroke or systemic embolism compared with warfarinThomas DeLoughery
Pageof 4